Glucose-insulin kinetics of a bioartificial pancreas made of an AN69 hydrogel hollow fiber containing porcine islets and implanted in diabetic mice

Artificial Organs

Volumn 22, Issue 4, 1998, Pages 291-299

  Delaunay, C ^a   Darquy, S ^a   Honiger, J ^b   Capron, F ^c   Rouault, C ^a   Reach, G ^a  

^a HÔTEL DIEU   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

AN69; Bioartificial pancreas; Islets of Langerhans; Xenotransplantation

Indexed keywords

BIOCOMPATIBILITY; FIBERS; INSULIN; MAMMALS;

AN69; BIO-ARTIFICIAL PANCREAS; DIABETIC MICE; HOLLOW FIBER; HYPERGLYCAEMIA; IN-VITRO; INSULIN KINETICS; ISLETS OF LANGERHANS; NORMAL TOLERANCES; XENOTRANSPLANTATION;

GLUCOSE;

ACRYLONITRILE; COPOLYMER; GLUCOSE; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL PANCREAS; CONTROLLED STUDY; ENCAPSULATION; FIBER; HYDROGEL; HYPERGLYCEMIA; IMPLANT; INSULIN RELEASE; INSULIN TOLERANCE TEST; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALIA; SUIDAE;

EID: 0031967865     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1998.05087.x     Document Type: Article

References (38)

1. Sutherland DER, Gruessner A, Moudry-Munns K, Cekka M. Tabulation of cases from the International Pancreas Transplant Registry and analysis of United Network for Organ Sharing Unites States Pancreas Transplant Registry data according to multiple variables. Transplant Proc 1993;25:1707-9.
2. International Islet Transplant Registry. Newsletter 1994;4: 3-19.
3. Mandel TE, Koulmanda M. Xenotransplantation of islets of Langerhans in diabetes mellitus. Transplant Proc 1994;26: 1110-2.
4. Barker C, Naji A, Silvers W. Immunologic problems in islet transplantation. Diabetes 1980;29(Suppl. 1):86-92.
5. Lim F, Sun A. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-10.
6. Reach G. Artificial and bioartificial replacement of the endocrine pancreas. Artif Organs 1992;160:61-70.
7. Reach G. Bioartificial pancreas. Diabet Med 1993;10:105-9.
8. Colton CK, Avgoustiniatos ES. Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 1991; 113:152-70.
9. Darquy S, Reach G. Immunoisolation of pancreatic cells by microencapsulation: An in vitro study. Diabetologia 1985;28: 776-80.
10. Zekorn T, Horcher A, Siebers U, Federlin K, Bretzel RG. Islet transplantation in immunoseparating membranes for treatment of insulin-dependent diabetes mellitus. Exp Clin Endocrinol 1995;103:136-9.
11. Niekrasz M, Ye Y, Rolf LL, Zuhdi N, Cooper DKC. The pig as organ donor for man. Transplant Proc 1992;24:625-6.
12. Andersson A, Groth CG, Korsgren O, Tibell A, Tollemar J, Kumagai M, Möller E, Bolinder J, Östman J, Bjoèrsdorf A, Hellerström C. Transplantation of porcine fetal islet-lake cell clusters to three diabetic patients. Transplant Proc 1992;24: 677-8.
13. Yamaguchi T, Mullen Y, Watanabe Y, Nomura Y, Cass D, Brunicardi C. Isolation and function of islets from young adult pig pancreas. Transplant Proc 1992;24:1010-2.
14. Groth CG. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1995;345:735.
15. Basta G, Falorni A, Osticioli L, Brunetti P, Calafiore R. Method for mass retrieval, morphologic, and functional characterization of adult porcine islets of Langerhans: A potential non human pancreatic tissue ressource for xenotransplantation in insulin-dependent diabetes mellitus. J Invest Med 1995; 43:555-66.
16. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995;4:415-36.
17. Honiger J, Darquy S, Reach G, Muscat E, Thomas M, Collier C. Preliminary report on cell encapsulation in a hydrogel made of biocompatible material, AN 69, for the development of a bioartificial pancreas. Int J Artif Organs 1994;17:46-52.
18. Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon N, Jacquot C, Herbelin A, Kazatchkine M. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in heamodialyzed patients: A randomized prospective study. Nephron 1991;59:279-85.
19. Gin Martin-Malo A, Castillo D, Castro M, Perez R, Rios A, Jaraba M, Aljama P. Biocompatibilily of dialysis membranes: A comparative study. Nephrol Dial Transplant 1991;2:55-8.
20. Ghysen J, De Plaen JF, Van Ypersele de Strihou C. The effect of membrane characteristics on tumor necrosis factor kinetics during haemodialysis. Nephrol Dial Transplant 1990;5:270-4.
21. Forêt M, Hachache T, Meftahi H, Milongo R, Kuentz F, Christollet M, Alibeu C, Cordonnier DJ. The long-term evaluation of the biocompatibility of nine different haemodialysis membranes. Life Support Syst 1987;5:203-6.
22. Gottlieb PA, Rossini AA, Mordes JP. Approaches to prevention and treatment of IDDM in animal models. Diabetes Care 1988;11(Suppl. 1):29-36.
23. Iwakiri R, Nagafuchi S, Kounoue E. Immunohistochemical study of insulitis induced by multiple low-doses of streptozotocin in CD-1 mice. Diabetes Res Clin Pract 1990;9:75-82.
24. Polo F, Monroy B, Di Maria S, Ruiu G, Darquy S, Petruzzo P, Arbet-Engels C, Cappai A, Brotzu G, Reach G. Islet isolation from the porcine pancreas, using a continuous digestion method. Xenotransplantation 1995;2:230-3.
25. Arbet-Engels C, Darquy S, Capron F, Reach G. Isolation of islets of Langerhans from the rat and pig pancreas using a modified UW solution from organ storage to islet purification. Diabete Metab 1993;20:590-6.
26. Arbet-Engels C, Darquy S, Capron F, Pueyo M, Di Maria S, Poitout V, Reach G. A one-step operator-independent method for isolating islets of Langerhans from the porcine pancreas. Artif Organs 1994;18:570-5.
27. Reach G, Jaffrin MY, Desjeux JF. A u-shaped bioartificial pancreas with rapid glucose-insulin kinetics: In vitro evaluation and kinetic modelling. Diabetes 1984;33:752-61.
28. Fan MY, Lum ZP, Fu XW, Levesque L, Tai IT, Sun AM. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 1990;39:519-22.
29. Fritschy WM, Strubbe JH, Wolters GHJ, Van Schilfgaarde R. Glucose tolerance plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts. Diabetologia 1991;34:542-7.
30. Theodorou N, Howeel S. An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 1979;27:350-3.
31. Lim F, Sun A. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-10.
32. Dionne KE, Hegre O, Scharp D, Lacy P, Lysaght M. Macroencapsulation of islets for the treatment of diabetes. In: Lanza RP, Chick WL, eds., Pancreatic islet transplantation, Volume III. Immunoisolation of pancreatic islets. Austin, TX: R.G. Landes Company, 1994:119-31.
33. Delaunay C, Honiger J, Darquy S, Capron F, Reach G. Bioartificial pancreas containing porcine islets of Langerhans implanted in low-dose streptozotocin diabetic mice: Effect of encapsulation medium. Diabetes Metab 1997;23:219-27.
34. Chaillous L, Darquy S, Maugendre S, Rivereau AS, Reach G, Saï P. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice. Diabetologia 1996;39:523-9.
35. De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R. Kinetics of intraperitoneally infused insulin in rats: Functional implications for the bioartificial pancreas. Diabetes 1996;45:1102-7.
36. Okamoto M, Kuzuga H, Imura H. Increased affinity of insulin receptors on hepatocytes from streptozotocin-induced diabetic rats. Endocrinology 1984;31:235-43.
37. Chipkin SR, Kelly KL, Ruderman NB. Hormone-fuel interrelationship: Fed state, starcation, and diabetes mellitus. In: Kahn CR, Weir GC, eds. Joslin's diabetes mellitus, 13th edition, Philadelphia: Lea & Febiger, 1994:997-1115.
38. Reach G, Assan R. Glucagon and diabetes mellitus. Diabete Metab 1979;5:189-94.